To assess the correlation chemotherapy effect on the tumor and in the patient derived organ like creation from pancreatic cancer cells.
Not Applicable
- Conditions
- Health Condition 1: C25- Malignant neoplasm of pancreas
- Registration Number
- CTRI/2017/05/008512
- Lead Sponsor
- Tata Memorial Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 20
Inclusion Criteria
Patients with metastatic pancreatic adenocarcinoma with liver metastasis
Treatment naive
Willing to consent for ultrasound guided core biopsy
ECOG PS 0 or 1
Exclusion Criteria
Metastasis to CNS
PS or general condition does not allow FOLFIRINOX based chemotherapy
Refused consent for participation in study
Severe medical conditions or illness including HIV HBV HCV infections.
Inadequate organ functions.
Previously treated with any chemo radio biological immunotherapy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method